In conclusion, our research uncovered a regulation wherein IGF2BP1 enhances aerobic glycolysis and immune escape in HCC by stabilizing PD-L1 mRNA, leading to reduced cytotoxicity of CD8+ T cells against HCC cells. The gene discussed is IGF2BP1; the disease is hepatocellular carcinoma.